George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Strong recovery from Revolution Bars, Vitec

Tue, 01st Mar 2022 18:09

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

PPHE Hotel Group Ltd - Amsterdam-based hotel owner and operator - For 2021, pretax loss narrows to GBP57.6 million from GBP94.7 million the year before, on revenue which grows 39% year-on-year to GBP141.4 million from GBP101.8 million, which marks a recovery to 40% of company's 20219 levels. RevPAR rises 22% to GBP35.9 from GBP29.4, and occupancy improves to 30.7% from 28.0% the prior year. Stronger performance is buoyed by the vaccination rollout in several countries, and the easing of Covid-related restrictions from the second quarter onwards. Will not declare a dividend for 2021, but will review future payouts depending on the recovery trajectory.

----------

Vitec Group PLC - Richmond, west London-based photography and video products maker - For 2021, swings to pretax profit of GBP29.6 million from a loss of GBP7.7 million, on revenue which grows 36% year-on-year to record levels of GBP394.3 million from GBP290.5 million, with increases across all divisions reflecting a strong market recovery. Declares final dividend of 24.0 pence per share, bringing the total payout to 35.0p, hiked from 4.5p. Looking ahead, Vitec says 2022 started well with record order intake, and remains confident despite short-term component shortages and inflation. Also looking to change group name at 2022 annual general meeting.

----------

Revolution Bars Group PLC - Ashton-under-Lyne, England-based bar chain - For the 26 weeks ended January 1, swings to pretax profit of GBP4.3 million from loss of GBP17.7 million the same period a year before, as total sales more than triple to GBP74.1 million from GBP21.6 million, aided by relaxed restrictions, allowing the return of students, office workers and increased staycations. Looking ahead, return to like-for-like sales growth in February, and expects annual adjusted earnings before interest, tax, depreciation and amortisation to be at the top end of market expectations, which is set between GBP8.0 million and GBP10.0 million.

----------

Volvere PLC - turnaround investment firm based in Leamington Spa, England - For 2021, expects to report a pretax profit of around GBP70,000, swinging from a loss of GBP550,000 the year before, on revenue which is set to grow 16% year-on-year to GBP35.6 million from GBP30.8 million, driven by a stronger performance from Shire Foods and Indulgence Patisserie Ltd. Looking ahead, challenges related to cost increases and labour availability in 2021 are present in 2022, however, environment for turnaround investing is improving.

----------

Uniphar PLC - Dublin-based healthcare services firm - For 2021, pretax profit increases 32% to EUR50.4 million from EUR38.4 million, on revenue which grows 6.5% year-on-year to EUR1.94 billion from EUR1.82 billion, with growth from all businesses, particularly Supply Chain & Retail which exceeds gross profit guidance. Looking ahead, keeps medium term guidance of mid-single digit growth in Commercial & Clinical, double-digit from Product Access and low-single digit in Supply Chain & Retail.

----------

essensys PLC - London-based software and cloud services for flexible workspace industry - For the six months ended January 31, revenue increases 3% year-on-year to GBP10.9 million, with continued demand from existing and new customers. Leads to anticipation that adjusted loss before interest, tax, depreciation and amortisation will be slightly better than management expectations. Looking ahead, to full year, adjusted Lbitda is set to be no more than GBP7 million, and revenue is expected to be at least GBP23.5 million, up 6.8% from GBP22 million the prior year. However, expansion and acceleration of its go-to-market activities has been delayed by "continued Covid related uncertainty". Also results in extended sales cycles leading to lower-than-anticipated sales bookings year-to-date.

----------

Fiske PLC - London-based stockbroker and investment manager - For the six months ended November 30, pretax loss narrows to GBP6,000 from GBP103,000 the same period a year before, as revenue grows 6% year-on-year to GBP2.9 million from GBP2.7 million, driven by a rise in investment management fee income on new client wins, more than offsetting a drop in commission income as market conditions were less volatile.

----------

PCI-PAL PLC - London-based call centre software provider - For the six months ended December 31, pretax loss narrows to GBP1.1 million from GBP2.3 million, on revenue which grows 72% year-on-year to GBP5.5 million from GBP3.2 million, as total annual contract value rises 36% to GBP11.3 million from GBP8.3 million. Looking ahead, makes strong start to the second half, with revenue momentum and the launch of its Australian business.

----------

Calnex Solutions PLC - provider of test and measurement solutions for the telecommunications sector - Reports strong levels of trading in the six months ending September 31, and subject to the fulfilment of scheduled orders in March, results for the year ending March 31 are set to e in line with market expectations. Calnex is on-track to begin the 2023 financial year with a record order book across all product lines, leading to revenue and operating profit for the year being set to come ahead of market expectations.

----------

European Smaller Companies Trust PLC - fund that seeks capital growth by investing in smaller companies in Europe outside the UK - For the six months ended December 31, net asset value total return is negative 1.4%, compared to the Euromoney Smaller European Cos (ex-UK) index, which made a positive return of 4.1%. As at December 31, net asset value per share drops 2.4% to 204.69 pence from 209.71p at the end of June. Declares dividend per share of 1.25 pence, up 22% from 1.025p a year prior.

----------

GetBusy PLC - Cambridge, England-based document management and productivity software provider - For 2021, pretax loss widens to GBP2.3 million from GBP1.1 million on rising costs, which more than offset a 8.5% rise in revenue to GBP15.4 million from GBP14.2 million, as annual recurring revenue grows 16% to GBP15.8 million, due to new business and ongoing demand. Looking ahead, for 2022 adjusted Ebitda is expected to approach breakeven, while strong ARR momentum will have group revenue at no less than GBP17.0 million.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis - For the six months ended December 31, pretax loss widens to AUD7.6 million from AUD5.9 million, due to higher administrative costs and one-off impairments arising from the MedicaNL acquisition. This was in spite of revenue more than tripling to AUD2.6 million from AUD741,911 through strong sales of Artemic, its Covid-19 supplement.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2023 08:25

IN BRIEF: MGC Pharmaceuticals raises GBP650,000 in subscription

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Conditionally raises GBP650,000, before expenses, through a placing and subscription of 541.7 million shares at a price of 0.12 pence per share. This represents a 57% discount from the closing price of 0.28p per share on Wednesday. The company also raises GBP50,000 from its Chief Executive Officer & Managing Director Roby Zomer in a convertible loan agreement.

Read more
12 Jul 2023 11:12

IN BRIEF: MGC Pharma to receive USD150,000 downpayment for AMC order

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Clarifies that it will receive USD150,000 down payment on a USD1 million order for ArtemiC placed by AMC last week. Says further USD850,000 will be paid upon completion of production and dispatch of the order, expected for September.

Read more
7 Jul 2023 09:41

MGC Pharmaceuticals shares up after USD1 million ArtemiC order

(Alliance News) - MGC Pharmaceuticals Ltd shares jumped on Friday morning after it announced a USD1 million order from AMC Pharma to produce ArtemiC, an over-the-counter version of CimetrA.

Read more
3 Jul 2023 17:31

TRADING UPDATES: Mycelx wins deal; 88 Energy buys in Texas

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrantholders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 May 2023 12:09

IN BRIEF: MGC Pharmaceuticals epilepsy treatment delivered in UK

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product, CannEpil, has been successfully delivered to its first UK patients through I Am Billy Foundation. Says CannEpil also has been delivered to its first patient in the UK through a named patient request programme.

Read more
30 May 2023 18:27

IN BRIEF: MGC Pharmaceuticals rejigs board to reflect strategic change

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says Brett Mitchell and Nativ Segev, will step down from the board, reflecting the changing direction of the company as it moves away from the medicinal cannabis sector toward a more pharma-focused business strategy. Stephen Parker, currently non-executive director, will replace Mitchell as interim non-executive chair. A new Australian non-executive director will also be appointed. Appoints Oberon Capital as joint broker in the UK with immediate effect alongside Peterhouse Capital.

Read more
13 Apr 2023 17:50

IN BRIEF: MGC Pharmaceuticals completes GBP2.1 million fundraise

MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Raises GBP2.1 million via a fundraising announced on Tuesday, which has now closed. Shares issued under the placing will be admitted to London Stock Exchange on April 18. In addition, MGC secures GBP256,590 in a separate offer to Australian and UK high-net-worth investors.

Read more
11 Apr 2023 14:10

IN BRIEF: MGC Pharmaceuticals says CannEpil available in UK

MGC Pharmaceuticals Ltd - Perth, Australia-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product CannEpil for patients suffering from refractory epilepsy is now available in the UK by named patient request to be prescribed by doctors. The product is now in the process of a clinical development programme.

Read more
3 Apr 2023 14:32

TRADING UPDATES: Lords Group buys Chiltern Timber; SRT wins contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday not separately reported by Alliance News:

Read more
21 Mar 2023 13:58

MGC Pharma's Covid-19 drug ArtemiC available over-the-counter in US

(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday said its ArtemiC product has now been listed as an over-the-counter, non-prescription drug in the US, while its supply and distribution partner AMC Holdings Inc has placed a USD2 million order.

Read more
15 Mar 2023 15:36

TRADING UPDATES: SigmaRoc Sweden boost; Mosman's Cinnabar-1 success

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
8 Mar 2023 18:24

TRADING UPDATES: Poolbeg patent boost; Resolute Mining resource up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Alliance News:

Read more
28 Feb 2023 14:34

EARNINGS UPDATES: Kitwave hails rise in annual revenue and profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.